Can Nitrites AMPk up Sirt-ainty to Treat HFpEF ?

[1]  W. Paulus,et al.  Myocardial Microvascular Inflammatory Endothelial Activation in Heart Failure With Preserved Ejection Fraction. , 2016, JACC. Heart failure.

[2]  M. Gladwin,et al.  SIRT3–AMP-Activated Protein Kinase Activation by Nitrite and Metformin Improves Hyperglycemia and Normalizes Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction , 2016, Circulation.

[3]  Frederick A. Masoudi,et al.  Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction , 2015 .

[4]  V. Melenovský,et al.  Sodium Nitrite Improves Exercise Hemodynamics and Ventricular Performance in Heart Failure With Preserved Ejection Fraction. , 2015, Journal of the American College of Cardiology.

[5]  M. Gladwin,et al.  Strategies to increase nitric oxide signalling in cardiovascular disease , 2015, Nature Reviews Drug Discovery.

[6]  J. Sadoshima,et al.  The role of sirtuins in cardiac disease. , 2015, American journal of physiology. Heart and circulatory physiology.

[7]  V. Dolinsky,et al.  Sirtuin-3 (SIRT3) Protein Attenuates Doxorubicin-induced Oxidative Stress and Improves Mitochondrial Respiration in H9c2 Cardiomyocytes* , 2015, The Journal of Biological Chemistry.

[8]  Thomas Danner,et al.  Phosphodiesterase 9A Controls Nitric-oxide Independent cGMP and Hypertrophic Heart Disease , 2015, Nature.

[9]  A. Webb,et al.  Paradoxical Normoxia-Dependent Selective Actions of Inorganic Nitrite in Human Muscular Conduit Arteries and Related Selective Actions on Central Blood Pressures , 2015, Circulation.

[10]  R. Townsend,et al.  Effect of Inorganic Nitrate on Exercise Capacity in Heart Failure With Preserved Ejection Fraction , 2015, Circulation.

[11]  Akshay S. Desai,et al.  Angiotensin-neprilysin inhibition versus enalapril in heart failure. , 2014, The New England journal of medicine.

[12]  D. Kass,et al.  Heart failure with preserved ejection fraction: mechanisms, clinical features, and therapies. , 2014, Circulation research.

[13]  C. Chu,et al.  Nitrite activates protein kinase A in normoxia to mediate mitochondrial fusion and tolerance to ischaemia/reperfusion. , 2014, Cardiovascular research.

[14]  W. Paulus,et al.  Myocardial Titin Hypophosphorylation Importantly Contributes to Heart Failure With Preserved Ejection Fraction in a Rat Metabolic Risk Model , 2013, Circulation: Heart Failure.

[15]  W. Paulus,et al.  A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. , 2013, Journal of the American College of Cardiology.

[16]  Manesh R. Patel,et al.  Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial. , 2013, JAMA.

[17]  J. Bronzwaer,et al.  Low Myocardial Protein Kinase G Activity in Heart Failure With Preserved Ejection Fraction , 2012, Circulation.

[18]  James O. Mudd,et al.  Pulmonary Capillary Wedge Pressure Augments Right Ventricular Pulsatile Loading , 2012, Circulation.

[19]  Jodi H. D. Long,et al.  Nitric oxide increases GLUT4 expression and regulates AMPK signaling in skeletal muscle. , 2007, American journal of physiology. Endocrinology and metabolism.

[20]  D. Kass,et al.  Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy , 2005, Nature Medicine.